Performance of laboratories in antimicrobial susceptibility testing of MB-16-09
| Antibiotics | MIC | Antibiotics | Disk | ||||||
|---|---|---|---|---|---|---|---|---|---|
| S | I | R | IND | S | I | R | IND | ||
| CLSI group A | |||||||||
| Azithromycin | 26 | Cefoxitin | 6 | ||||||
| Erythromycin | 181 | 21 | Clarithromycin | 1 | |||||
| Clindamycin | 210 | Erythromycin | 19 | 1 | |||||
| Penicillin G | 3 | 190 | Clindamycin | 22 | |||||
| Trimethoprim/Sulfamethoxa | 203 | Penicillin G | 9 | 12 | |||||
| Trimethoprim/Sulfamethoxa | 18 | ||||||||
| Other CLSI groups | |||||||||
| Ciprofloxacin | 109 | 1 | Amikacin | 1 | |||||
| Daptomycin | 36 | Chloramphenicol | 5 | ||||||
| Gentamicin | 74 | Ciprofloxacin | 14 | ||||||
| Levofloxacin | 4 | Doxycycline | 1 | ||||||
| Linezolid | 194 | Gentamicin | 15 | ||||||
| Quinupristin/Dalfopristin | 4 | Levofloxacin | 3 | ||||||
| Rifampicin | 45 | Linezolid | 5 | ||||||
| Rifampin | 97 | Moxifloxacin | 1 | ||||||
| Teicoplanin | 27 | Netilmicin | 1 | ||||||
| Telithromycin | 5 | Ofloxacin | 1 | ||||||
| Tetracycline | 202 | Rifampin | 3 | ||||||
| Tigecycline | 1 | Teicoplanin | 5 | ||||||
| Vancomycin | 219 | Tetracycline | 11 | ||||||
| Vancomycin | 13 | ||||||||
| Unacceptable | |||||||||
| Cefazolin | 1 | Cefazolin | 3 | ||||||
| Gentamicin-high | 1 | Cefepime | 1 | ||||||
| Nitrofurantoin | 2 | Cefmetazole | 1 | ||||||
| Streptomycin-high | 1 | Cefoperazone/Sulbactam | 1 | ||||||
| Cefotaxime | 3 | ||||||||
| Ceftazidime | 1 | 1 | |||||||
| Ceftriaxone | 1 | 1 | |||||||
| Cefuroxime axetil | 1 | ||||||||
| Cefuroxime sodium | 1 | ||||||||
| Cephalothin | 1 | ||||||||
| IND | 1 | ||||||||
| Amoxicillin/Clavulanic acid | 1 | Ampicillin | 3 | ||||||
| Ampicillin | 7 | Imipenem | 2 | ||||||
| Aztreonam | 1 | Meropenem | 2 | ||||||
| Cefoxitin | 5 | Oxacillin | 13 | 6 | |||||
| Imipenem | 1 | Oxacillin (Cefoxitin) | 2 | ||||||
| Oxacillin | 167 | 34 | Piperacillin/Tazobactam | 2 | |||||
| Oxacillin (Cefoxitin) | 9 | 3 | |||||||
Abbreviations: MIC, minimum inhibitory concentration; S, susceptible; I, intermediate; R, resistance; IND, indeterminate; CLSI, Clinical and Laboratory Standards Institute.